The Life Sciences Solutions segment consists of the portfolio of reagents, instruments, and consumables. This is mostly composed of nondurable disposable supplies and items used for therapeutic purposes, such as disposable gloves, surgical masks, needles, and syringes that are used for research, new drug discovery, and production and diagnostic purposes.
The segment was established in 2014 with the acquisition of Life Technologies and consists of the former Life Technologies business and the Thermo Fisher Biosciences business. In the same year, it accounted for 25% of the total revenues of the company.
View more information: https://marketrealist.com/2016/01/an-overview-of-thermo-fisher-scientifics-business-model/